Shares of Biodexa Pharmaceuticals skyrocketed nearly 50% on Monday, hitting their highest level since early December. The ...

Biodexa (NASDAQ:BDRX) stock soared 76% in morning trading after the company announced it has received FDA Fast Track designation for its drug eRapa for the treatment of familial adenomatous polyposis, ...

Here is how argenex SE (ARGX) and Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) have performed compared to their sector so far this year.

16:52 EST Biodexa Pharmaceuticals (BDRX ... and streamline your search for investment opportunities using Tipranks' Stock Screener Published first on TheFly – the ultimate source for real ...

Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 4.9%.

Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative ...

Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 6.2%.

September 26, 2024 Biodexa Pharmaceuticals PLC (Biodexa or the Company) Interim results for the six months ended June 30, 2024 Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an ...